Product · #24 of 27 · multi-symptom

Womaness Me.No.Pause.

Capsule from Womaness, made by Womaness (Well Found, Inc.). Daily serving: 1 capsule.

Last updated · Price and ratings checked Nov 19, 2026

In short: Womaness Me.No.Pause. scores 40.6/100 in our ranking (#24 of 27). It costs $1.57 a day at the regular price. Evidence: Pycnogenol 60 mg (below studied doses), low-dose ashwagandha; best ingredient grade C (Ashwagandha). No NSF registry listing was confirmed.

Pros

  • None stood out.

Cons

  • No NSF registry listing confirmed.
  • Expensive: $1.57 a day at the label dose.
  • Evidence: Pycnogenol 60 mg (below studied doses), low-dose ashwagandha.
  • Key active is below the dose used in the main studies.

Flags

None found

Score breakdown

Evidence
17/40
NSF-verified testing
4/20
Value ($/day)
10.1/20
Ingredients
6/10
Amazon rating
3.5/10

How we score

Full label: what's in it

Supplement Facts actives per daily serving (1 capsule). Source: label or official page, checked Nov 19, 2026.
Ingredient (as labeled)Per dayEvidence page
Bacognize Bacopa monnieri (whole herb)300 mgNot in our evidence library
Ashwagandha root (Withania somnifera)100 mgAshwagandha C
Pycnogenol pine bark extract60 mgPycnogenol (pine bark) C

Label photo dated 2021; the product page names the same three actives.

Evidence

Our evidence score: 17/40, because: Pycnogenol 60 mg (below studied doses), low-dose ashwagandha.

Product-level research: we found no published trial of this exact product, so its evidence comes from studies of its ingredients.

Ingredient evidence

  • Ashwagandha C (100 mg here)
    Ashwagandha root extract has been studied for occasional stress, sleep quality and common symptoms in perimenopause and menopause* in a few small placebo-controlled trials, all run in India. The Menopause Society 2023: Not assessed.
  • Pycnogenol (pine bark) C (60 mg here)
    Pycnogenol, a French maritime pine bark extract, has been studied in three controlled trials for occasional hot flashes and sleep problems in perimenopause*. The Menopause Society 2023: Not assessed.

Studies

Studies on its ingredients (5)
  • Effect of an ashwagandha (Withania Somnifera) root extract on climacteric symptoms in women during perimenopause: A randomized, double-blind, placebo-controlled study.

    Gopal S, Ajgaonkar A, Kanchi P et al. · J Obstet Gynaecol Res 2021 · Ashwagandha

    100 Indian women in perimenopause took ashwagandha root extract (300 mg twice a day) or placebo for 8 weeks. Menopause symptoms and quality of life improved more with ashwagandha, and hormone levels shifted. The study was short and not yet repeated outside India.

    Who
    100 perimenopausal women (91 completed)
    Dose
    ashwagandha root extract 300 mg twice daily
    Duration
    8 weeks
    Result
    Total MRS and MENQoL improved vs placebo; estradiol up, FSH/LH down.
    Funding
    Not stated in abstract; Indian investigators (ingredient-supplier funding typical but not verified). Funding not stated

    PubMed · Full text (DOI)

  • A prospective, randomized, double-blind, placebo-controlled study on efficacy and safety of Ashwagandha root extract (Withania somnifera) for managing menopausal symptoms in women.

    Vani I, Muralidhar G, Rao BS · Front Reprod Health 2025 · Ashwagandha

    60 Indian women took ashwagandha root extract or placebo for 8 weeks; symptoms, hot flashes and stress improved more with ashwagandha. Small and short.

    Who
    60 women aged 45–55
    Dose
    ashwagandha root extract
    Duration
    56 days
    Result
    MRS, hot-flash events and stress scores improved vs placebo.
    Funding
    Authors declared no conflicts. Independent / academic

    PubMed · Full text (DOI)

  • Effects of Withania somnifera root extract on sleep quality, body composition, and menopausal symptoms in postmenopausal women: a randomized, double-blind, placebo-controlled trial.

    Obhrai S, Shenoy S, Arora M · Menopause 2026 · Ashwagandha

    66 Indian postmenopausal women took ashwagandha 600 mg a day or placebo for 12 weeks; sleep and menopause symptoms improved more with ashwagandha.

    Who
    66 postmenopausal women (63 completed)
    Dose
    ashwagandha root extract 600 mg/day
    Duration
    12 weeks
    Result
    Better sleep quality (PSQI -5.2 vs -0.8), menopause symptoms and body fat vs placebo; no BMD change.
    Funding
    No conflicts reported. Independent / academic

    PubMed · Full text (DOI)

  • Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women: a randomized, double-blind, placebo-controlled trial.

    Kohama T, Negami M · J Reprod Med 2013 · Pycnogenol (pine bark)

    170 Japanese women took a low dose of French maritime pine bark extract (60 mg a day) or placebo for 12 weeks. Symptoms, especially hot flashes and sleep, improved more than placebo, though placebo also helped a lot.

    Who
    170 perimenopausal women (Japan)
    Dose
    Pycnogenol 30 mg twice daily
    Duration
    12 weeks
    Result
    Kupperman -56% vs -39% placebo (P<.05); hot flashes and sleep improved.
    Funding
    Not stated in abstract (Horphag Research, maker, typically supports Pycnogenol trials; not verified). Funding not stated

    PubMed

  • A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women.

    Yang HM, Liao MF, Zhu SY et al. · Acta Obstet Gynecol Scand 2007 · Pycnogenol (pine bark)

    About 200 Taiwanese women took 200 mg pine bark extract or placebo for 6 months, and symptoms improved more with the extract.

    Who
    200 enrolled, 155 completed (Taiwan)
    Dose
    Pycnogenol 200 mg/day
    Duration
    6 months
    Result
    All climacteric symptoms improved vs placebo; antioxidant status improved.
    Funding
    Not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

The Menopause Society's 2023 statement is in the study library.

Price

Regular one-time price$46.99 (30 units, 30 days at label dose)
Cost per day$1.57
SubscriptionAmazon S&S $42.15
Price notesBF sale $32.89 (-30%); 90-day 3-pack $140.97; Amazon B096H6M6GM $46.83
In stock when checkedYes
CheckedNov 19, 2026

Ratings

Amazon: ★ 4.3 from 151 ratings on Amazon (checked Nov 19, 2026)

Brand site: ★ 4.9, 52 reviews on womaness.com (checked Nov 19, 2026). Brand-site reviews are moderated by the brand.

Star ratings reflect buyer satisfaction, not clinical effect.

Certifications and claims

Verified in a public registry

  • No registry listing found.

Claims made by the brand

  • “vegan” Brand claim
  • “gluten-free” Brand claim
  • “hormone/phytoestrogen-free” Brand claim
  • “non-GMO” Brand claim
  • “label tested with 50+ gynecologists/PCPs” Brand claim

Registry check: NSF/ANSI 173 ('Womaness'): not found

Who's behind it

BrandWomaness
Owner / companyWomaness (Well Found, Inc., St. Paul, MN per label).
FoundersMichelle Jacobs & Sally Mueller.
Where it's madeMade in USA (Amazon brand claim). Brand claim
Medical advisors named
  • Anita Sadaty, MD (OB-GYN), quoted on product page
Sourcewomaness.com

Flags & safety

Legal, regulatory and quality flags

No lawsuits, regulator actions or watchdog complaints found in our search for this product or brand.

Ingredient safety notes

  • Ashwagandha: Rare liver-injury case reports exist in the literature (not reviewed here); avoid in pregnancy and with thyroid medication — standard cautions (not verified here). Trials reported raised estradiol, lower FSH/LH. Unverified
  • Pycnogenol (pine bark): Well tolerated in trials.

Sources

Talk to a clinician first

The Menopause Society's 2023 nonhormone position statement does not recommend any dietary supplement or herbal remedy for hot flashes, because the research is limited or mixed. Hormone therapy is an option for many women, and the statement lists non-hormonal options with evidence behind them: CBT, clinical hypnosis, SSRIs/SNRIs, gabapentin, fezolinetant (Level I), oxybutynin (I–II), weight loss, stellate ganglion block (II–III).

If hot flashes, night sweats, sleep or mood are affecting your life, talk to a clinician first. If you still want to try a supplement, the rankings below show what is actually in each one, what the research found, and who is behind it. Sources: position statement (PDF) · PubMed.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.